Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Chronic Graft-Versus-Host Disease (cGVHD) Exacerbation after Sars-Cov-2 Covid Vaccination

Andrew D. Trunk, Samuel Shewan, Catherine J. Lee, Daniel R. Couriel

Blood (2021) 138 (Supplement 1): 1813.

DOI: https://doi.org/10.1182/blood-2021-149937

Published: 2021

Journal Articles

Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Adults

Rohtesh S. Mehta, MDMPH,MS, Shernan G. Holtan, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Stephen R. Spellman, Mukta Arora, MD, Daniel R. Couriel, MD, Amin M. Alousi, Joseph Pidala, MD PhD, Daniel J. Weisdorf, MD

Blood (2017) 130 (Supplement 1): 517.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.517.517

Published: 2017

Journal Articles

Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Pediatric Patients

Blood (2017) 130 (Supplement 1): 2053.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2053.2053

Published: 2017

Journal Articles

Upper Gastrointestinal Acute Graft-Versus-Host Disease Adds Minimal Prognostic Value When Present in Isolation or in Addition to Grade I or Other Grade II-Defining GvHD Manifestations

Sarah Nikiforow, MD PhD, Michael Hemmer, MS, Stephen R. Spellman, MBS, Amin M. Alousi, MD, Daniel R. Couriel, MD, Joseph A Pidala, MD, PhD, Mukta Arora, MD, Corey S Cutler, MD MPH, Tao Wang, PhD

Blood (2015) 126 (23): 857.

DOI: https://doi.org/10.1182/blood.V126.23.857.857

Published: 2015

Journal Articles

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Attaphol Pawarode, MD, Steven Goldstein, MD, Daniel R. Couriel, MD, Thomas Braun, PhD, John M. Magenau, MD, Mary Mansour Riwes, DO, Brian Parkin, Vedran Radojcic, MD, David Frame, PharmD, Sung Choi, MD, James Connelly, MD, John E. Levine, MD MS, Gregory A. Yanik, MD, Pavan Reddy, MD

Blood (2015) 126 (23): 1907.

DOI: https://doi.org/10.1182/blood.V126.23.1907.1907

Published: 2015

Journal Articles

Outcomes of Grades II-IV Acute Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: How Much Progress Was Achieved?

Hanna Jean Khoury, MD, Tao Wang, PhD, Mukta Arora, MD, Michael Hemmer, MS, Stephen R. Spellman, MBS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Joseph A. Joseph, MD

Blood (2015) 126 (23): 3132.

DOI: https://doi.org/10.1182/blood.V126.23.3132.3132

Published: 2015

Journal Articles

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Alvaro Urbano-Ispizua, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Mukta Arora, MD MS, Stephen R. Spellman, MBS

Blood (2014) 124 (21): 4383.

DOI: https://doi.org/10.1182/blood.V124.21.4383.4383

Published: 2014

Journal Articles

Ex Vivo Pharmacologic Modulation in a Nutrient-Rich Medium to Accelerate Engraftment of Human Umbilical Cord Blood

Corey S Cutler, MD MPH, Daniel Shoemaker, PhD, Peter Westervelt, MD PhD, Daniel R. Couriel, MD, Sumithra Vasu, MBBS, Luis M. Isola, MD, Chatchada Karanes, MD, Laura Newell, MD, Betsy Rezner, BS, Lisa Guerrettaz, PhD, David Robbins, BS, Amanda Medcalf, BS, MT(ASCP), Scott Wolchko, MS, John Ferraro, MBA, Pratik S. Multani, MD MS

Blood (2014) 124 (21): 3807.

DOI: https://doi.org/10.1182/blood.V124.21.3807.3807

Published: 2014

Journal Articles

Prognostic Value of TGFβ at Diagnosis of Chronic GvHD

Rima M Saliba, PhD, Carrie Kitko, MD, Pavan Reddy, MD, John M. Magenau, MD, Attaphol Pawarode, Steven Goldstein, Daniel R. Couriel, MD

Blood (2014) 124 (21): 5875.

DOI: https://doi.org/10.1182/blood.V124.21.5875.5875

Published: 2014

Journal Articles

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis

Carrie L. Kitko, John E. Levine, Barry E. Storer, Xiaoyu Chai, David A. Fox, Thomas M. Braun, Daniel R. Couriel, Paul J. Martin, Mary E. Flowers, John A. Hansen, Lawrence Chang, Megan Conlon, Bryan J. Fiema, Rachel Morgan, Prae Pongtornpipat, Kelly Lamiman, James L. M. Ferrara, Stephanie J. Lee, Sophie Paczesny

Blood (2014) 123 (5): 786–793.

DOI: https://doi.org/10.1182/blood-2013-08-520072

Published: 2014

Includes: Supplemental data

Journal Articles

Trends In Incidence, Presentation, and Outcomes Of Chronic Graft-Versus-Host Disease In Allogeneic Transplantation- Report From The Center For International Blood and Marrow Transplant Research

Sally Arai, MD, Mukta Arora, MD, MS, Tao Wang, PhD, Wensheng He, PhD, MS, Daniel R. Couriel, MD, Alvaro Urbano-Ispizua, MD, Corey S. Cutler, MD, Stephen Spellman, MBS, Steven Z. Pavletic, MD

Blood (2013) 122 (21): 3309.

DOI: https://doi.org/10.1182/blood.V122.21.3309.3309

Published: 2013

Journal Articles

Pneumocystis Jirovecii Pneumonia In Recipients Of Autologous Hematopoietic Stem Cell Transplantation: A 10-Year Cohort Study

Kadee J Raser, M.S., PA-C, Gregory A. Yanik, MD, John M. Magenau, M.D., Steven C. Goldstein, MD, Attaphol Pawarode, Carrie Kitko, M.D., John E. Levine, M.D., M.S., David Hanauer, M.S., M.D., Daniel R. Couriel, MD

Blood (2013) 122 (21): 3372.

DOI: https://doi.org/10.1182/blood.V122.21.3372.3372

Published: 2013

Journal Articles

Application Of BOS 0-Potential Criteria As a Predictor For Bronchiolitis Obliterans Syndrome In Allogeneic Stem Cell Transplant Patients

Sameem Abedin, MD, Gregory A. Yanik, MD, John M. Magenau, MD, Steven C. Goldstein, MD, Attaphol Pawarode, MD, John E. Levine, M.D., M.S., Carrie L. Kitko, MD, Daniel R. Couriel, MD

Blood (2013) 122 (21): 2060.

DOI: https://doi.org/10.1182/blood.V122.21.2060.2060

Published: 2013

Journal Articles

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

Blood (2013) 122 (21): 706.

DOI: https://doi.org/10.1182/blood.V122.21.706.706

Published: 2013

Journal Articles

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Andrew C. Harris, M.D., James L.M. Ferrara, M.D., D.Sc., Thomas M. Braun, Ph.D., Daniel R. Couriel, M.D., Sung W. Choi, M.D., Carrie Kitko, M.D., Steven Goldstein, John M. Magenau, M.D., Sophie Paczesny, M.D., Ph.D, Attaphol Pawarode, Pavan Reddy, M.D., Gregory A. Yanik, Austin Taylor, James Connelly, M.D., Craig A. Byersdorfer, M.D., Ph.D., John E. Levine, M.D., M.S.

Blood (2012) 120 (21): 463.

DOI: https://doi.org/10.1182/blood.V120.21.463.463

Published: 2012

Journal Articles

Risk Factors for Non-Relapse Mortality in Chronic Graft Versus Host Disease: Predicting Outcomes At Disease Onset

Carrie L Kitko, Rima M Saliba, PhD, Sophie Paczesny, MD, PhD., Maggi Kennel, BS, MS, Sung W. Choi, M.D., Pavan Reddy, M.D., John E. Levine, M.D., M.S., Daniel R. Couriel, M.D.

Blood (2012) 120 (21): 1941.

DOI: https://doi.org/10.1182/blood.V120.21.1941.1941

Published: 2012

Journal Articles

Targeting Histone Deacetylases As a New Strategy for Graft Versus Host Disease Prevention

Blood (2012) 120 (21): 740.

DOI: https://doi.org/10.1182/blood.V120.21.740.740

Published: 2012

Journal Articles

Plasma biomarkers of lower gastrointestinal and liver acute GVHD

Andrew C. Harris, James L. M. Ferrara, Thomas M. Braun, Ernst Holler, Takanori Teshima, John E. Levine, Sung W. Choi, Karin Landfried, Koichi Akashi, Mark Vander Lugt, Daniel R. Couriel, Pavan Reddy, Sophie Paczesny

Blood (2012) 119 (12): 2960–2963.

DOI: https://doi.org/10.1182/blood-2011-10-387357

Published: 2012

Includes: Supplemental data

Journal Articles

A Phase II Trial of Combined Bendamustine, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma (MM) Patients Who Are Not Candidates for High-Dose Chemotherapy: Results of a Planned Interim Safety Analysis

Jesus G. Berdeja, MD, Daniel R. Couriel, MD, Patrick Murphy, MD, Ralph V. Boccia, MD, Victor Priego, MD, John D. Hainsworth, MD, Inés M. Macias-Pérez, PhD, Ian W. Flinn, MD, PhD

Blood (2011) 118 (21): 2943.

DOI: https://doi.org/10.1182/blood.V118.21.2943.2943

Published: 2011

Journal Articles

A Phase II Randomized Bayesian Study of Very Low Dose Subcutaneous Decitabine Administered Daily or Weekly Times Three in Patients with Lower Risk Myelodysplastic Syndrome (MDS).

Guillermo Garcia-Manero, MD, Daniel R. Couriel, MD, Francesco Paolo Tambaro, MD, PhD, Nashat Gabrail, Ahmed Nadeem, MD, Tapan Kadia, MD, Elias Jabbour, MD, Gautam Borthakur, MD, Stefan Faderl, MD, Willie Newsome, RN, Hui Yang, MD, PhD, Kevin Chen, Karen Stein, MD, Hagop Kantarjian, MD

Blood (2009) 114 (22): 119.

DOI: https://doi.org/10.1182/blood.V114.22.119.119

Published: 2009

NARROW

Chronic Graft-Versus-Host Disease (cGVHD) Exacerbation after Sars-Cov-2 Covid Vaccination

Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Adults

Graft-Versus-Host Disease (GVHD)-Free Relapse-Free Survival (GRFS) and Chronic Gvhd (CRFS) in Alternative Donor Hematopoietic Cell Transplantation (HCT) in Pediatric Patients

Upper Gastrointestinal Acute Graft-Versus-Host Disease Adds Minimal Prognostic Value When Present in Isolation or in Addition to Grade I or Other Grade II-Defining GvHD Manifestations

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Outcomes of Grades II-IV Acute Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: How Much Progress Was Achieved?

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Ex Vivo Pharmacologic Modulation in a Nutrient-Rich Medium to Accelerate Engraftment of Human Umbilical Cord Blood

Prognostic Value of TGFβ at Diagnosis of Chronic GvHD

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis

Trends In Incidence, Presentation, and Outcomes Of Chronic Graft-Versus-Host Disease In Allogeneic Transplantation- Report From The Center For International Blood and Marrow Transplant Research

Pneumocystis Jirovecii Pneumonia In Recipients Of Autologous Hematopoietic Stem Cell Transplantation: A 10-Year Cohort Study

Application Of BOS 0-Potential Criteria As a Predictor For Bronchiolitis Obliterans Syndrome In Allogeneic Stem Cell Transplant Patients

The CIBMTR Chronic GVHD Risk Group Predicts Major Outcomes In An Independent Validation Cohort

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Risk Factors for Non-Relapse Mortality in Chronic Graft Versus Host Disease: Predicting Outcomes At Disease Onset

Targeting Histone Deacetylases As a New Strategy for Graft Versus Host Disease Prevention

Plasma biomarkers of lower gastrointestinal and liver acute GVHD

A Phase II Trial of Combined Bendamustine, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma (MM) Patients Who Are Not Candidates for High-Dose Chemotherapy: Results of a Planned Interim Safety Analysis

A Phase II Randomized Bayesian Study of Very Low Dose Subcutaneous Decitabine Administered Daily or Weekly Times Three in Patients with Lower Risk Myelodysplastic Syndrome (MDS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only